Randomized Withdrawal Study in Patients With Schizophrenia
Public ClinicalTrials.gov record NCT06961968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Blind, Randomized Withdrawal Study in Patients With Schizophrenia Receiving Either Iloperidone Long-Acting Injection (LAI) or Placebo Injection
Study identification
- NCT ID
- NCT06961968
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Vanda Pharmaceuticals
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- iloperidone Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 13, 2025
- Primary completion
- Oct 31, 2027
- Completion
- Oct 31, 2027
- Last update posted
- Jan 11, 2026
2025 – 2027
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Rogers | Arkansas | 72758 | Recruiting |
| Vanda Investigational Site | Costa Mesa | California | 92626 | Recruiting |
| Vanda Investigational Site | Lemon Grove | California | 91945 | Recruiting |
| Vanda Investigational Site | Oceanside | California | 92056 | Recruiting |
| Vanda Investigational Site | Pico Rivera | California | 90660 | Recruiting |
| Vanda Investigational Site | San Diego | California | 92123 | Recruiting |
| Vanda Investigational Site | Walnut Creek | California | 94596 | Recruiting |
| Vanda Investigational Site | North Miami | Florida | 33161 | Recruiting |
| Vanda Investigational Site | Atlanta | Georgia | 30328 | Recruiting |
| Vanda Investigational Site | Peachtree Corners | Georgia | 30071 | Recruiting |
| Vanda Investigational Site | Chicago | Illinois | 60641 | Recruiting |
| Vanda Investigational Site | Flowood | Mississippi | 39232 | Recruiting |
| Vanda Investigational Site | Saint Charles | Missouri | 63304 | Recruiting |
| Vanda Investigational Site | St Louis | Missouri | 63141 | Recruiting |
| Vanda Investigational Site | Las Vegas | Nevada | 89119 | Recruiting |
| Vanda Investigational Site | Marlton | New Jersey | 08053 | Recruiting |
| Vanda Investigational Site | Staten Island | New York | 10314 | Recruiting |
| Vanda Investigational Site | Austin | Texas | 78754 | Recruiting |
| Vanda Investigational Site | Houston | Texas | 77081 | Recruiting |
| Vanda Investigational Site | Irving | Texas | 75062 | Recruiting |
| Vanda Investigational Site | Richardson | Texas | 75080 | Recruiting |
| Vanda Investigational Site | Bellevue | Washington | 98007 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06961968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06961968 live on ClinicalTrials.gov.